Authors
Latest:
The Future of Multiple Sclerosis TreatmentAhmed Obeidat, MD, PhD; Benjamin Greenberg, MD; and Hesham Abboud, MD, share their hopes about the evolution of future mutiple sclerosis care and express their gratitude for the next generation of neurologists.
Latest:
The Paradigm Shift in Therapeutic Intervention for ALS: Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMSThe Bushell Chair of Neurology at the University of Sydney offered his perspective on phase 2 data of CNM-Au8 in amyotrophic lateral sclerosis and spoke to the advances that the field has made in recent years. [WATCH TIME: 3 minutes]
Latest:
Understanding Brain Differences in MRI Markers, Sleep-Disordered Breathing of Latino Individuals: Alberto Ramos, MD, MSPH, FAASMThe director of the Sleep Disorders program at the University of Miami discussed his research regarding the association of sleep disordered breathing and total brain volumes in Latino individuals. [WATCH TIME: 3 minutes]
Latest:
Highlights of the Advanced Therapeutics in Movement and Related Disorders Congress: Jean Hubble, MDThe semi-retired neurologist and consultant with the PMD Alliance offered her takeaways from the 2022 ATMRD Congress in Washington, DC, and her advice for younger clinicians getting into the field. [WATCH TIME: 3 minutes]
Latest:
Managing Insomnia: Practical Advice for Community PhysiciansClosing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
Latest:
Evolving Rehabilitation Strategies for Multiple SclerosisAhmed Obeidat, MD, PhD; Francois Bethoux, MD; and Nicholas C. Ketchum, MD, discuss recent advancements and future directions in rehabilitation strategies for multiple sclerosis.
Latest:
The Benefits of a New Therapy for Pompe Disease: Tahseen Mozaffar, MD, FAANOn Rare Disease Day, the director of the Division of Neuromuscular Diseases at UC Irvine commented on the potential of AT845 for this patient population. [WATCH TIME: 3 minutes]
Latest:
The Relationship Between Epstein-Barr Virus and Multiple SclerosisThe paradigm-shifting evidence of the link between MS and EBV does not exist in isolation. In fact, the relationship has been suspected for more than 40 years, and evidence therein has been accumulating over the past 2 decades.
Latest:
Adding Experience to the National Health Institute Council: Amy Brin, MSN, MA, PCNS-BCThe chief executive officer of the Child Neurology Foundation provided insight on her new position at the National Health Institute’s National Advisory Neurological Disorders and Stroke Council. [WATCH TIME: 4 minutes]
Latest:
Preventing Epilepsy Through Antiseizure Medication in Tuberous Sclerosis Complex: Gabrielle Rushing, PhDThe director of research at the TSC Alliance spoke with us at the 2022 AES Conference about future research to be conducted on patients with TSC such as the PREVeNT trial. [WATCH TIME: 6 minutes]
Latest:
Future Outlook for Alzheimer’s DiseaseDrs Atri, Cohen, Sabbagh and McDade share their enthusiasm and optimism about the future outlook for Alzheimer’s disease.
Latest:
Connecting ALS: How New Drug Coverage Decisions Are MadeIn this episode of Connecting ALS, Dave R. Zook, JD, an advisor with expertise in federal regulatory policy, speaks to the process of making drug coverage decisions for newly approved therapies.
Latest:
Ana Pereira, MD: Repurposing Riluzole for Alzheimer DiseaseThe assistant professor of neurology and neuroscience at Mount Sinai Medical Center detailed the promise marked by the results of a recent pilot trial of riluzole in Alzheimer disease.
Latest:
Future of Cognition in Multiple SclerosisAhmed Obeidat, MD, PhD; Randall Schapiro, MD, FAAN; and Jeffrey Wilken, PhD, share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.
Latest:
A New Approach to Protein Misfolding in Parkinson DiseasePreviously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.
Latest:
Less Invasive Epilepsy Surgery May Help Turn Candidates Into ConsultsRecent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.
Latest:
Future Directions for the Management of MigraineBradley Torphy, MD, and Julio R. Vieira, MD, share unmet needs and clinical pearls for the management of migraine.
Latest:
Discontinuing Disease-Modifying Therapies in Multiple Sclerosis: Deborah Miller, PhDThe staff member at the Mellen Center for Multiple Sclerosis discussed reasons why patients may stop treatment, as well as strategies for maintaining communication with the healthcare team in the event of discontinuation. [WATCH TIME: 5 minutes]
Latest:
Creating Positive, Helpful Work Environments for Patients With NMOSD: Farrah Mateen, MD, PhDThe associate director of the Multiple Sclerosis & Neuromyelitis Optica Unit at Massachusetts General Hospital discussed the ways employers and clinicians can alleviate work hardships experienced by patients with NMOSD. [WATCH TIME: 3 minutes]
Latest:
Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MDThe neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]
Latest:
Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MDOutlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]
Latest:
Pros and Cons of Telemedicine for Multiple Sclerosis: Mitzi Joi Williams, MDThe founder and CEO of Joi Wellness Group Multiple Sclerosis Center explained her reasoning as to why she hopes telemedicine is here to stay. [WATCH TIME: 4 minutes]
Latest:
Advice for Advanced Practice Providers in Managing Sleep DisordersAdvanced practice practitioners share final pearls with their colleagues for the management of sleep disorders.
Latest:
AUPN 2022 Veterans Health Administration WorkshopGlenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]
Latest:
Evolution of NMOSD Research and Implications for Other Autoimmune Diseases: Michael Levy, MD, PhDIn a recent interview, the associate professor at Harvard Medical School spoke about patient-centered research in the advancing treatment for patients with NMOSD. [WATCH TIME: 5 minutes]
Latest:
Expensive Antiseizure Medications Cause for Concern for Patients with Epilepsy: Deepti Zutshi, MD, FAANThe associate professor of neurology at Wayne State University in Detroit, Michigan, spoke about expensive antiseizure medications for epilepsy along with spending for Medicare and Medicaid at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]
Latest:
Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome OptimizationSurgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?
Latest:
The Mobile Stroke Unit Paradigm Shift for EMS: Thomas TopleyThe executive director of the Bensalem Rescue Squad spoke specifically to how the MSU has shifted the paradigm of care that EMS can provide to individuals in the community. [WATCH TIME: 4 minutes]
Latest:
AUPN 2022 Veterans Health Administration WorkshopGlenn Graham, MD, PhD; and Sharyl Martini, MD, PhD, moderate a discussion with 4 clincial experts to advance specialized clinical care, education and research for Veterans with movement disorders, multiple sclerosis, epilepsy and seizures, and headache. [WATCH TIME: 1 hour, 52 minutes]
Latest:
Advancements in the Alzheimer Disease Field: Michael Weiner, MDThe director of the Brain Health Registry discussed advancements in AD, following the publication of a systematic review on the predictors of Aß.
